Press Room

Webinar: High performance solutions for DPI delivery: new formulation and device platforms

Wednesday, October 04, 2023 - 16:00
Location: online

October 4th, 2023

11:00 am EDT | 4:00 pm GMT | 5:00 pm CEST | 8:00 am PDT

Registrations to the webinar are subject to approval.


Register now!


Featured Hovione experts in this webinar
Webinar_Inhalation_Sunriser_Speaker Susana Saldanha | Hovione


Webinar_Inhalation_Sunriser_Speaker Sofia Silva | Hovione


Susana Saldanha, M.Sc.
R&D Manager, Inhalation and Advanced Drug Delivery
Sofia Silva, M.Sc.
R&D Manager, Analytical Development


This webinar will address the most relevant solutions for dry powder inhaler (DPI) development covering both formulation and device development, as well as process optimization and analytical characterization, under an integrated development approach. 

DPIs are the dosage form of choice for delivering high doses of inhaled drugs and achieving maximum delivery efficiency to patients. This presentation will focus on new formulation platforms, aiming to address the pharmacokinetics requirements of the target drug and indication, coupled with a new high performance, high-dose device platform, the Sunriser® DPI

This integrated approach is designed to maximize drug delivery efficiency while maintaining safety, and is able to address a diversified array of diseases. Register Now!


Key Learning Objectives:

  • Gain insights on novel formulation development strategies for DPIs, to be able to improve drug delivery efficiency even with high drug loads;
  • Understand the potential of wet milling and dry milling capabilities for boosting the fine particle dose of DPI formulations;
  • Discover analytical characterization techniques, for differentiated formulations, to further understand product properties that impact drug delivery and aerodynamic performance;
  • Understand features associated with a novel high efficiency device platform, the Sunriser® capsule-based Dry Powder Inhaler;
  • Network with industry peers and experts during the live Q&A session.

Who Should Attend:

  • Pharmaceutical researchers and scientists
  • CMC experts on inhalation drug delivery
  • Business development, portfolio management and technology licensing experts
  • Inhalation product development professionals
  • Respiratory therapeutics specialists

Register now and join us

Our experts will reply to your questions during the live Q&A session.



Also in the Press Room

Also in Events